Skip to main content
. Author manuscript; available in PMC: 2022 Aug 15.
Published in final edited form as: Cancer Res. 2022 Feb 15;82(4):648–664. doi: 10.1158/0008-5472.CAN-21-1705

Table 1.

Clinical annotations and histopathological information of LUAD specimens analyzed in this study

PRIMARY FIBROBLAST CULTURES
Specimen NFs TAFs TCFs Tumor size (cm) Differentiation status Prior Treatment Comorbordities Smoker status Common mutations Classification Node status
1 X X X 3.5 Well None None Never EGFR exon 19 deletion Acinar 85%, lepidic 10%, pipillary 5% N0
2 X X X 2.6 Moderate None Hypertension Former None Papillary 50%, acinary 30%, lepidic 20% N1
3 X X X 3.5 Moderate None Hypertension Never None Acinar 70%, papillary 25%, lepidic 5% N1
LUNG ADENOCARCINOMA FROZEN SPECIMEN
Specimen Sex Stage Tumor size (cm) Differentiation status Prior Treatment Comorbordities Smoker status Common mutations Classification Node status
59 F 2 2.1 Unknown None Hypercholesterolemia, hypertension, disc rupture L4-L5 Never Unknown Invasive adenocarcinoma, papillary predominant N0
TUMOR MICROARRAY COHORT
Number of patients Grade Histology Stage Cancer cell/Stroma compartmentalization
Poor Moderate Well Unknown Adeno Broncho-alveolar Mixed adeno/broncho-alveolar 1 2 3 4 Y N
160 54 138 53 15 217 32 11 146 70 43 1 30 230